0001193125-26-170557
SEC filingQ1 2026 delivered revenue contraction to $3.0B and net loss expansion to -$58M amid hospital divestitures, offset by same-store revenue growth and supplies efficiency gains that stabilized operating income near prior-year levels.
Operating income remained stable at $281 million, down just 1.1%, with the operating margin at 9.5%. This steadiness highlights the company's ability to control operating expenses relative to the topline contraction, preserving profitability at the operating level despite divestiture impacts.
The bottom line faced headwinds, with net income swinging to a $58 million loss from a $13 million loss, driven by an elevated tax provision. This increase and effective tax rate change were primarily attributable to non-deductible goodwill associated with divested hospitals, illustrating the one-time tax consequences of strategic asset sales.
These results position CYH to navigate federal deficit pressures on government healthcare programs, which management anticipates will persist. The focus on same-store growth and expense efficiency amid divestitures signals a strategy to streamline the hospital portfolio for long-term resilience in a challenging industry.